Potential role of cinnamon in the prevention and management of diabetic vascular complications in humans

被引:0
|
作者
Girgiss, Mina Wassef [1 ]
Nicola, Wassef Girgiss [2 ]
Habib, Dawoud Fakhry [3 ]
Youness, Eman Refaat [3 ]
Ahmed, Nadia Mohamed [3 ]
Elnemr, Mohamed Elsayed [4 ]
机构
[1] NRC, Med Div, Dept Complementary Med, Cairo, Egypt
[2] NRC, Med Div, Dept Internal Med, Cairo, Egypt
[3] NRC, Med Div, Med Biochem Dept, Cairo, Egypt
[4] 6th October Univ, Fac Med, Dept Internal Med, Giza, Egypt
来源
BIOSCIENCE RESEARCH | 2018年 / 15卷 / 01期
关键词
Cinnamon; Type 2 diabetes mellitus; Paraoxonase-1; Malondialdehyde; Cholesterol; Apo Cs; Vascular tree;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Experimental and human studies proved cinnamon to have some biological activities like those of insulin hormone. It increases glucose uptake by the different cells and increases glycogen storage. It targets PPAR a and. nuclear receptors which affect lipid and carbohydrate metabolism. Also it possesses antioxidant effects. We aim to study the effect of cinnamon on the vascular tree in obese type 2 diabetic patients. Sixteen obese type 2 diabetic female patients, each of them was given 1.8 gm of cinnamon powder in capsule form daily in three divided doses for three weeks. Their fasting serum paraoxonase-1, malondialdehyde, total cholesterol, LDL, HDL, Apo C II and Apo C lll were estimated before and after three consecutive weeks of cinnamon intake. Cinnamon significantly increased paraoxonase-1 and reduced malondialdehyde. It reduced total cholesterol, LDL cholesterol and increased HDL cholesterol. Again, it significantly reduced Apo C ll and decreased Apo C lll. In Conclusion cinnamon can be used as a supplementary agent in the management of atherosclerotic risk conditions such as obesity, type 2 diabetes mellitus, hypertension and dyslipidemia. Cinnamon tackled several important facets in the process of atherogenesis. It improved the oxidative stress, the lipid profile and the inflammatory state.
引用
收藏
页码:348 / 356
页数:9
相关论文
共 50 条
  • [31] Molecular targets of diabetic vascular complications and potential new drugs
    Da Ros, R
    Assaloni, R
    Ceriello, A
    CURRENT DRUG TARGETS, 2005, 6 (04) : 503 - 509
  • [32] PREVENTION OF DIABETIC COMPLICATIONS
    不详
    LANCET, 1951, 260 (JUN23): : 1354 - 1354
  • [33] A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications
    Huang, Dan-Dan
    Shi, Guangjiang
    Jiang, Yaping
    Yao, Chao
    Zhu, Chuanlin
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 125
  • [34] MANAGEMENT OF SICK DIABETIC - PHYSICIANS ROLE IN PREVENTION OF DIABETIC COMA
    TAFT, P
    VARLEY, CC
    BREIDAHL, HD
    MEDICAL JOURNAL OF AUSTRALIA, 1973, 1 (24) : 1197 - 1200
  • [35] The Role of Advanced Glycation End Products in Diabetic Vascular Complications
    Rhee, Sang Youl
    Kim, Young Seol
    DIABETES & METABOLISM JOURNAL, 2018, 42 (03) : 188 - 195
  • [37] The potential role of lncRNAs in diabetes and diabetic microvascular complications
    Chen, Yanxia
    He, Yinxi
    Zhou, Hong
    ENDOCRINE JOURNAL, 2020, 67 (07) : 659 - 668
  • [38] The prevention of diabetic microvascular complications of diabetes: Is there a role for lipid lowering?
    Leiter, LA
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 68 : S3 - S14
  • [39] Endothelial Glycocalyx Hyaluronan Regulation and Role in Prevention of Diabetic Complications
    Wang, Gangqi
    Tiemeier, Gesa L.
    van den Berg, Bernard M.
    Rabelink, Ton J.
    AMERICAN JOURNAL OF PATHOLOGY, 2020, 190 (04): : 781 - 790
  • [40] PREVENTION AND MANAGEMENT OF POLYTETRAFLUOROETHYLENE GRAFT COMPLICATIONS IN PERIPHERAL VASCULAR RECONSTRUCTION
    ANSEL, AL
    JOHNSON, JM
    AMERICAN JOURNAL OF SURGERY, 1982, 144 (02): : 228 - 230